ICD-9 | ICD-10 | Description |
---|---|---|
202.80 | xx | Lymphoma, other, unspecified site |
200.4* | C83.1* | Mantle cell lymphoma |
202.10 | C84.0* | Mycosis fungoides |
202.70 | C84.4* | Peripheral T-cell lymphoma, NOS (PTCL) |
Lymphoma is a type of blood cancer originating in the lymphatic system and occurs when the cells behave abnormally. Lymphomas are classified to ICD-9-CM categories 200 to 202. The specific code assignment depends on the cell type as documented by the physician.
Instead, it would be assigned to a code from category 196. Documentation of lymphoma in remission is still assigned to the appropriate code from categories 200 to 202.
There are 3 ICD-9-CM codes below 204.1 that define this diagnosis in greater detail. Do not use this code on a reimbursement claim. A chronic leukemia characterized by abnormal b-lymphocytes and often generalized lymphadenopathy.
Many fifth-digit subclassifications pertain to lymph node sites. If the lymphoma affects lymph nodes in more than one region of the body, assign the fifth digit of 8. If the lymphoma is located in an extranodal site or solid organ (eg, brain), then the fifth digit 0 will be assigned.
ICD-9-CM Diagnosis Code 202.8 : Other malignant lymphomas.
ICD-9-CM Codes - C82. 00 (unspecified site) - 202.00 (nodular lymphoma, unspecified site, extranodal and solid organ sites.)
ICD-10 code Z85. 72 for Personal history of non-Hodgkin lymphomas is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 code C85. 9 for Non-Hodgkin lymphoma, unspecified is a medical classification as listed by WHO under the range - Malignant neoplasms .
The primary site for nodal lymphomas is coded to lymph nodes (C770-C779). The primary site for extranodal lymphoma is coded to a site other than lymph nodes (primary sites other than C770-C779).
Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission. C91. 51 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C91.
Z85. 72 - Personal history of non-Hodgkin lymphomas. ICD-10-CM.
ICD-10 code C81. 9 for Hodgkin lymphoma, unspecified is a medical classification as listed by WHO under the range - Malignant neoplasms .
Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network. The lymphatic system includes the lymph nodes (lymph glands), spleen, thymus gland and bone marrow. Lymphoma can affect all those areas as well as other organs throughout the body.
Non-Hodgkin lymphoma (also known as non-Hodgkin's lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in white blood cells called lymphocytes, which are part of the body's immune system.
200.50 - Primary central nervous system lymphoma, unspecified site, extranodal and solid organ sites. ICD-10-CM.
Hodgkin lymphoma and high-grade non-Hodgkin lymphoma often goes into complete remission and needs no further treatment. However, some people relapse and need more treatment.
Lymphomas are classified to ICD-9-CM categories 200 to 202. The specific code assignment depends on the cell type as documented by the physician.
If the disease is completely cured and documented as “history of,” assign code V10.79 as a secondary diagnosis. Lymphomas are divided into two main categories: Hodgkin’s and non-Hodgkin’s lymphoma.
A fifth-digit subclassification is required to identify the site of the organ or lymph node involved as follows: • 8: lymph nodes of multiple sites. Many fifth-digit subclassifications pertain to lymph node sites. If the lymphoma affects lymph nodes in more than one region of the body, assign the fifth digit of 8.
Many fifth-digit subclassifications pertain to lymph node sites. If the lymphoma affects lymph nodes in more than one region of the body, assign the fifth digit of 8. If the lymphoma is located in an extranodal site or solid organ (eg, brain), then the fifth digit 0 will be assigned.
Treatment may involve one or a combination of the following: chemotherapy, radiation or biologic therapy, radioimmunotherapy, or stem cell or bone marrow transplantation.
A lymphoma, regardless of the number of sites involved, is not considered metastatic, and should be coded to the 200-202 categories” ( AHA Coding Clinic for ICD-9-CM, 1992, second quarter, page 3). It is common for solid tumors (classified to categories 140 to 199) to metastasize to lymph nodes.
When an episode of care involves the surgical removal of a neoplasm, primary or secondary site, followed by adjunct chemotherapy or radiation treatment during the same episode of care , the neoplasm code should be assigned as principal or first-listed diagnosis, using codes in the 140-198 series or where appropriate in the 200-203 series.
Symptoms, signs, and ill-defined conditions listed in Chapter 16 characteristic of, or associated with, an existing primary or secondary site malignancy cannot be used to replace the malignancy as principal or first-listed diagnosis, regardless of the number of admissions or encounters for treatment and care of the neoplasm.
For Lymphoma, the guidance is do not assign a code for personal history unless the physician specifically documents that the patient has no evidence of disease AND that the lymphoma is now "history of" and not active.
For Leukemia, the Navigator explains patients with leukemia are seldom found to have no disease so it's rare to use a history code for them. And advises not to use a "history of" code for patients in Remission. Be sure to use Remission codes. Hope that helps.
All information indicates that Non-Hodgkin's Lymphoma is a "chronic condition" and should be coded from the "C" section of ICD10. There are no "remission" codes but there is a "Z" code for "Personal History of". I am confused with the information as it seems to contradict itself, once you have this type of Lymphoma there is no cure, ...
You are correct that Lymphoma is a systemic disease so you have always have it . Lymphomas are coded from the C81 to C88 categories in ICD-10. I was taught to code it active based on the current or most recent site (s) of disease and to never be coded to history UNLESS the physician specifically states that the patient is completely disease-free ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
Symptoms include the painless enlargement of lymph nodes, spleen, or other immune tissue. Other symptoms include fever, weight loss, fatigue, or night sweats. A lymphoma, previously known as hodgkin's disease, characterized by the presence of reed-sternberg cells.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
An obsolete term referring to hodgkin lymphoma. Hodgkin disease is a type of lymphoma. lymphoma is cancer of lymph tissue found in the lymph nodes, spleen, liver, and bone marrow. The first sign of hodgkin disease is often an enlarged lymph node. The disease can spread to nearby lymph nodes.
Hodgkin lymphoma. Clinical Information. A cancer of the immune system that is marked by the presence of a type of cell called the reed-sternberg cell. The two major types of hodgkin lymphoma are classical hodgkin lymphoma and nodular lymphocyte-predominant hodgkin lymphoma.
There are two distinct subtypes: nodular lymphocyte predominant hodgkin lymphoma and classical hodgkin lymphoma. Hodgkin lymphoma has a bimodal age distribution, and involves primarily lymph nodes. Current therapy for hodgkin lymphoma has resulted in an excellent outcome and cure for the majority of patients.